• E-mail :[email]
  • Phone : +33 1 49 28 46 44
  • Location : Paris, France
Last update 2021-03-02 11:29:40.803

Alexandre Escargueil PhD in Molecular and Cellular Biology

Course and current status

Current position

Since 2020: Co-head of the Biomedical Humanities Initiative – Sorbonne University, Paris, France.

Since 2015: Head and Founder of the Bachelor Degree in Innovative Public Health Science – Faculty of Science and Engineering, Sorbonne University, Paris, France.

Since 2014: Full Professor in Cell Biology and Genetics (Sorbonne University), Research Centre Saint-Antoine – INSERM UMR_S 938 & SU Paris, France

Since 2014: Co-head and co-Founder  of the Interdisciplinary Ph.D. Program in Oncology – Institute of Oncology – Faculty of Medicine, Sorbonne University, Paris, France.

 

Previous positions

2008-2014: Assistant Professor in Cell Biology and Genetics (University Pierre et Marie Curie), Research Centre Saint-Antoine – INSERM UMR_S 938 & UPMC Paris, France

2007-2008: Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil (Visiting Professor)

2004-2007: INSERM U673, Hospital Saint-Antoine, Paris, France (Post-doctoral Fellow)

2001-2004: University of Oxford, Sir William Dunn School of pathology, Oxford, United-Kingdom (Post-doctoral Fellow)

2000-2001: Commissariat à l'Energie Atomique, Gif-sur-Yvette, France (Military Service)

1995-2000: Institute Gustave-Roussy, Villejuif, France (Ph. D.).

 

Current editorial activity

Since 2020: Editor-in-Chief, section "Cancer Therapy" – Cancers (ISSN: 2072-6694).

Since 2019: Member of the Editorial Board – Cancers (ISSN: 2072-6694).

Since 2016: Member of the International Editorial Board – Tumori Journal (ISSN: 0300-8916).

 

Current advisory committees 

Since 2019: Member of the Board for strategic guidance of the Institute of Oncology – APHP.6-Sorbonne University.

Since 2017: Member of the Board of Directors of the Department of Biology – Faculty of Science & Engineering, Sorbonne University.

Since 2017: Member of the Scientific Committee – Inserm (“Institut national de la santé et de la recherche médicale”).

Scientific summary

My work is focused on the interplay between cancer biology and therapeutics. It concerns the development of novel anticancer agents and combinations and their associated biomarkers based on a mechanistic understanding. This includes both DNA-targeted agents and drugs targeting oncogenic signaling pathways.

Image d’exemple